UNIRETIC (nda020729)- (12.5MG;7.5MG,12.5MG;15MG,25MG;15MG)

Generic Name	HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE	Innovator	UCB INC
Dosage	12.5MG;7.5MG,12.5MG;15MG,25MG;15MG
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2007-Feb-24	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Uniretic® is indicated for treatment of patients with hypertension.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
2	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
12.5MG;7.5MG	**	**	-	-	-
12.5MG;15MG	**	**	-	-	-
25MG;15MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of UNIRETIC